TLDR Grayscale is launching the first US spot Chainlink ETF on December 2, converting its private LINK trust that started in 2020 Bloomberg Intelligence analyst Eric Balchunas predicts over 100 crypto ETFs could launch in the next six months The ETF will track LINK’s spot price and include staking returns for investors Bitwise is preparing [...] The post Chainlink (LINK) Price: Grayscale to Launch First US Spot ETF on December 2 appeared first on CoinCentral.TLDR Grayscale is launching the first US spot Chainlink ETF on December 2, converting its private LINK trust that started in 2020 Bloomberg Intelligence analyst Eric Balchunas predicts over 100 crypto ETFs could launch in the next six months The ETF will track LINK’s spot price and include staking returns for investors Bitwise is preparing [...] The post Chainlink (LINK) Price: Grayscale to Launch First US Spot ETF on December 2 appeared first on CoinCentral.

Chainlink (LINK) Price: Grayscale to Launch First US Spot ETF on December 2

TLDR

  • Grayscale is launching the first US spot Chainlink ETF on December 2, converting its private LINK trust that started in 2020
  • Bloomberg Intelligence analyst Eric Balchunas predicts over 100 crypto ETFs could launch in the next six months
  • The ETF will track LINK’s spot price and include staking returns for investors
  • Bitwise is preparing a competing Chainlink ETF to launch soon after Grayscale’s product
  • Recent altcoin ETFs for Solana, XRP, and Dogecoin have seen strong demand, with Canary Capital’s XRP ETF pulling in $58 million on day one

Grayscale is preparing to launch the first spot Chainlink exchange-traded fund in the United States. The product is expected to begin trading on December 2, according to Nate Geraci, co-founder of ETF Institute.

The new ETF will convert Grayscale’s existing Chainlink private trust into a publicly traded fund. The trust was originally formed in late 2020.

This marks the first time US investors can access spot LINK exposure through a regulated ETF structure. The fund will track the spot price of Chainlink tokens and generate returns from staking LINK where allowed.

Chainlink (LINK) PriceChainlink (LINK) Price

Bloomberg Intelligence senior ETF analyst Eric Balchunas confirmed the December 2 timeline. He shared internal listings data showing Grayscale’s product queued for launch this week.

Balchunas also stated that the US market could see more than 100 new crypto ETFs over the next six months. He said at least five spot crypto funds are scheduled to launch within the next six days.

The regulatory environment for crypto ETFs has shifted this year under new SEC leadership. Products tied to Solana, XRP, and Dogecoin have all received approval in recent months.

Competition Heats Up

Bitwise Asset Management is also preparing its own Chainlink ETF. The competing product is waiting for approval and could launch shortly after Grayscale’s fund.

This sets up a race between the two asset managers to capture institutional and retail investment flows. Both firms are targeting investors who want exposure to Chainlink’s oracle network.

Grayscale has described Chainlink as critical infrastructure connecting blockchain networks to traditional financial systems. The protocol provides data feeds, pricing information, and settlement triggers to both crypto and conventional platforms.

Altcoin ETF Wave Continues

The Chainlink ETF launch follows a busy period for altcoin investment products. Issuers have rolled out funds for several cryptocurrencies beyond Bitcoin and Ethereum in recent weeks.

Canary Capital’s XRP ETF debuted with $58 million in net inflows on its first day. This was the highest opening-day total for any ETF in 2025.

Bitwise’s Solana Staking ETF has accumulated over $660 million in assets within three weeks of launching. The fund has not recorded a single day of outflows since its debut.

Grayscale also launched spot XRP and Dogecoin ETFs last month. The New York Stock Exchange approved both products for trading, with shares beginning to trade on the exchange’s Arca platform.

The surge in altcoin ETF launches reflects growing investor appetite for crypto exposure beyond Bitcoin. Asset managers are racing to bring new products to market while regulatory conditions remain favorable.

Grayscale’s Chainlink Trust will be the latest in a series of conversions from private trusts to public ETFs. The firm has used this approach with several of its other crypto products over the past year.

The post Chainlink (LINK) Price: Grayscale to Launch First US Spot ETF on December 2 appeared first on CoinCentral.

Market Opportunity
Chainlink Logo
Chainlink Price(LINK)
$13.7
$13.7$13.7
-1.93%
USD
Chainlink (LINK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23